{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "EMA Herbal Substance|Uses" in comments (approximate match)
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(1998)
Source URL:
First approved in 1998
Source:
21 CFR 352
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2011)
Source URL:
First approved in 1998
Source:
21 CFR 352
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Tonic Gel with horse chestnut and leech extract Horse Force by Zeldis-farma, Ooo
(2015)
Source URL:
First approved in 1995
Source:
21 CFR 352
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
First approved in 1995
Source:
21 CFR 341
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
M006
(2012)
Source URL:
First approved in 1990
Source:
21 CFR 352
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT00103012: Phase 4 Interventional Completed Healthy
(2005)
Source URL:
First approved in 1984
Source:
21 CFR 341
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Class:
STRUCTURALLY DIVERSE
Status:
US Approved OTC
Source:
21 CFR 349.12(a)(3) ophthalmic:demulcents hypromellose
Source URL:
First approved in 1974
Source:
NDA200890
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Plalab Placenta Peeling by Renocell Co., Ltd
Source URL:
First approved in 2005
Source:
M006
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
CONCEPT